TO STUDY THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN POLYCYSTIC OVARIAN SYNDROME
Phase 3
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2019/11/022187
- Lead Sponsor
- DR NILINA P R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women Among Reproductive Age Group HavingPolycystic Ovarian Syndrome With Ovarian Volume Greater Than 10cc In Any One Of The Ovaries
Exclusion Criteria
Cases Having Endocrinal Abnormalities Similar To Polycystic Ovarian Syndrome
Type 2 Diabetes Mellitus Taking Metformin Tablets
Pregnant And Lactating Mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms do homoeopathic medicines target in reducing ovarian volume in PCOS patients?
How does homoeopathic treatment compare to standard-of-care therapies like metformin in PCOS management?
Are there specific biomarkers that predict response to homoeopathic interventions in PCOS subtypes?
What adverse events are associated with homoeopathic medicines in PCOS clinical trials?
What combination approaches or competitor drugs are being explored alongside homoeopathic treatments for PCOS?